18 Jul 2024 --- US-based InMode secures an additional FDA 510(k) clearance for its Morpheus8 technology — the “first and only” fractional radiofrequency microneedling technology for contraction of soft tissue. The medical technology provider says Morpheus8 can be used in dermatology procedures involving the coagulation and contraction of soft tissue or for hemostasis. It notes the second FDA clearance emphasizes the “versatility” of the technology.
